Ugandan Pharmaceutical Plant Wins WHO Approval for ARV Manufacturing
March 11, 2010
The WHO recently approved the manufacturing of antiretrovirals (ARVs) in Kampala, Uganda, by the pharmaceutical company Quality Chemicals Industries, New Vision/allAfrica.com reports. The plant is the first to win WHO approval outside of South Africa and is expected to "reduce the monthly cost of ARVs from sh30,000 to sh16,000 (29 to 14 USD)," according to the news service. The company "intends to export to neighbouring Kenya, Burundi, Rwanda, Tanzania, the Democratic Republic of Congo and Sudan," New Vision/allAfrica.com writes (Nabusoba, 3/10).
This article was provided by Henry J. Kaiser Family Foundation. It is a part of the publication Kaiser Daily Global Health Policy Report. Visit the Kaiser Family Foundation's website to find out more about their activities, publications and services.